Skip to content
Screener

Medpace Holdings, Inc. MEDP Total Current Liabilities

Total Current Liabilities at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$15.07B+18.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$2.12B-21.8%
IQVIA logo
IQVIAIQV
$8.82B+16.4%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$963.7M+2.3%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$17.77M+0.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$21.64M

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except share amounts)As of / June 30,2026As of / December 31,2025
Accrued expenses451,076408,382
Advanced billings (includes $13.1 million and $12.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)904,722854,390
Other current liabilities42,10452,834
Total current liabilities1,435,4291,343,748
Operating lease liabilities120,100113,643
Deferred income tax liability8,2071,355
Other long-term liabilities59,58457,655
Total liabilities1,623,3201,516,401

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s total current liabilities?
Medpace Holdings, Inc. (MEDP) reported total current liabilities of $1.44B in Q2 2026.
How has Medpace Holdings, Inc.'s total current liabilities changed year-over-year?
Medpace Holdings, Inc.'s total current liabilities increased by 17.6% year-over-year, from $1.22B to $1.44B.
What is the long-term trend for Medpace Holdings, Inc.'s total current liabilities?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s total current liabilities has grown at a 25.0% compound annual growth rate (CAGR), from $440.11M to $1.34B.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Medpace Holdings, Inc.'s total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude